Neisseria meningitidis

Outbreaks of Neisseria meningitidis are classically associated with populations living in close quarters, such as college dormitories and military barracks. Incidence peaks in infants and adolescents/young adults.

🔗 original

Transmission occurs person-to-person via inhalation of respiratory droplets. Humans are the only natural reservoir, with asymptomatic nasopharyngeal carriage being the primary source of spread.

🔗 original

Neisseria meningitidis is a Gram-negative, kidney-bean shaped diplococcus. On a CSF Gram stain, it is classically seen intracellularly within polymorphonuclear leukocytes (neutrophils).

🔗 original

A major virulence factor is its antiphagocytic polysaccharide capsule, which is the basis for serogrouping (A, B, C, W, Y) and the primary target for most meningococcal vaccines.

🔗 A clear, protective dome or shell represents an antiphagocytic polysaccharide capsule.

Individuals with anatomic or functional asplenia are at high risk for fulminant sepsis from encapsulated organisms like N. meningitidis due to impaired opsonization and clearance.

🔗 The polysaccharide capsule is a major virulence factor that prevents opsonization and phagocytosis. The spleen-shaped drone represents the spleen's critical role in clearing encapsulated organisms. The drone being actively blocked by the capsule illustrates why patients without a functional spleen (asplenia) are at high risk for severe, invasive infection.

Inherited deficiency of the terminal complement components (C5-C9), which form the Membrane Attack Complex (MAC), confers a dramatically increased susceptibility to recurrent invasive Neisseria infections.

🔗 Deficiency in the terminal complement components (C5-C9), which form the Membrane Attack Complex (MAC), is a major risk factor for recurrent invasive Neisseria infections.

N. meningitidis secretes an IgA protease that cleaves secretory IgA at its hinge region, facilitating bacterial colonization on mucosal surfaces like the nasopharynx.

🔗 N. meningitidis produces an IgA protease, which cleaves secretory IgA at its hinge region, disabling mucosal immunity.

The outer membrane contains lipooligosaccharide (LOS), a potent endotoxin that triggers a massive inflammatory response, leading to septic shock, disseminated intravascular coagulation (DIC), and endothelial damage.

🔗 The student's blanket has a pattern of lumpy, short-chained sugar molecules with lipid anchors (LOS). The blanket is emitting sparks that are hitting a nearby model ship, causing it to break into tiny pieces, symbolizing DIC.

N. meningitidis is selectively isolated on Thayer-Martin agar, a chocolate agar containing Vancomycin, Colistin (a polymyxin), and Nystatin to inhibit other organisms.

🔗 N. meningitidis is cultured on Thayer-Martin medium, a chocolate agar with selective antibiotics: Vancomycin (inhibits Gram-positives), Colistin (inhibits other Gram-negatives), and Nystatin (inhibits fungi).

N. meningitidis ferments both glucose and maltose. This distinguishes it from N. gonorrhoeae, which ferments only glucose.

🔗 N. meningitidis ferments both glucose and maltose; the key differentiator from N. gonorrhoeae is maltose fermentation.

Presents as acute bacterial meningitis with fever, nuchal rigidity, and headache. CSF analysis shows high opening pressure, neutrophilic pleocytosis, high protein, and low glucose.

🔗 Bacterial meningitis CSF shows neutrophilic pleocytosis, low glucose, and high protein.

Meningococcemia (sepsis) is characterized by fever and a petechial or purpuric rash from LOS-induced vasculitis. The rash typically does not blanch with pressure.

🔗 Meningococcemia causes a non-blanching petechial rash with a central distribution, sparing the wrists and ankles, unlike the rash of RMSF.

Waterhouse-Friderichsen syndrome is a catastrophic complication of meningococcemia, defined by bilateral adrenal hemorrhage, leading to acute adrenal insufficiency and profound shock.

🔗 Waterhouse-Friderichsen syndrome is bilateral adrenal hemorrhage leading to acute adrenal insufficiency and shock.

First-line treatment for invasive meningococcal disease is a third-generation cephalosporin, such as ceftriaxone, which has excellent CNS penetration.

🔗 original

Chemoprophylaxis with agents like rifampin is recommended for close contacts to eradicate nasopharyngeal carriage and prevent secondary cases.

🔗 original

A quadrivalent conjugate vaccine links the polysaccharide capsules of serogroups A, C, W, and Y to a carrier protein, eliciting a robust, T-cell dependent immune response.

🔗 original

The serogroup B capsule is poorly immunogenic as it mimics human neural cell adhesion molecules (NCAM). A separate, recombinant protein-based vaccine is required for protection.

🔗 original